Overexpression of RBM34 Promotes Tumor Progression and Correlates with Poor Prognosis of Hepatocellular Carcinoma.
Journal of Clinical and Translational Hepatology（2023）
摘要
Our study suggests that RBM34 may serve as a new prognostic marker and therapeutic target of HCC.
更多查看译文
关键词
Hepatocellular carcinoma,Immune infiltration,Oncogene,RBM34,Sorafenib resistance
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要